Alligator Bioscience Awarded New Patent for its Protein Optimization Technology FIND in Japan
"The newly-granted patent in Japan confirms the strength of our expanding portfolio." said Gun-Britt Fransson, chief executive officer of Alligator Bioscience. "The patent covers the core of our company, our proprietary FIND® technology. This platform enables us to build a competitive pipeline of novel and improved versions of biopharmaceuticals. We focus on candidates in inflammation and cancer and our disclosed programs targets the C5a receptor (C5aR), Interleukin 1 (IL-1) and Interleukin 23 (IL-23). We believe this patent will be of crucial importance for our future development on the Japanese market."
Most read news
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.